These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6825384)
1. A comparison of drug product information in four national compendia. Alloza JL; Lasagna L Clin Pharmacol Ther; 1983 Mar; 33(3):269-77. PubMed ID: 6825384 [TBL] [Abstract][Full Text] [Related]
2. A Collaborative Assessment Among 11 Pharmaceutical Companies of Misinformation in Commonly Used Online Drug Information Compendia. Randhawa AS; Babalola O; Henney Z; Miller M; Nelson T; Oza M; Patel C; Randhawa AS; Riley J; Snyder S; So S Ann Pharmacother; 2016 May; 50(5):352-9. PubMed ID: 26917822 [TBL] [Abstract][Full Text] [Related]
3. Comparison of potentially hepatotoxic drugs among major US drug compendia. Guo JJ; Wigle PR; Lammers K; Vu O Res Social Adm Pharm; 2005 Sep; 1(3):460-79. PubMed ID: 17138490 [TBL] [Abstract][Full Text] [Related]
4. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs. Chao SD; Maibach HI Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682 [TBL] [Abstract][Full Text] [Related]
5. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events. Cohen JS Arch Intern Med; 2001 Apr; 161(7):957-64. PubMed ID: 11295958 [TBL] [Abstract][Full Text] [Related]
7. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications. Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056 [TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of four drug interaction compendia. Vitry AI Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171 [TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents: comparing off-label uses among authoritative drug compendia. Thompson DF; Keefe CC Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046 [TBL] [Abstract][Full Text] [Related]
10. Implementing a Process to Review Product-Specific Misinformation in Online Drug Information Compendia. Talwar SR; Crudele NT; Dankiewicz EH; Randhawa AS; Haddox JD Ther Innov Regul Sci; 2015 Mar; 49(2):262-268. PubMed ID: 30222421 [TBL] [Abstract][Full Text] [Related]
11. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Olvey EL; Clauschee S; Malone DC Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252 [TBL] [Abstract][Full Text] [Related]
12. Different indications, warnings and precautions, and contraindications for the same drug--an international comparison of prescribing information for commonly used psychiatric drugs. Pfistermeister B; Schenk C; Kornhuber J; Bürkle T; Fromm MF; Maas R Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):329-33. PubMed ID: 23280570 [TBL] [Abstract][Full Text] [Related]
14. 'Off-label' prescribing, the Physician's Desk Reference and the court. Spector RA; Marquez E J La State Med Soc; 2011; 163(5):276-80. PubMed ID: 22272550 [TBL] [Abstract][Full Text] [Related]
15. The Physicians' Desk Reference. Problems and possible improvements. Cohen JS; Insel PA Arch Intern Med; 1996 Jul; 156(13):1375-80. PubMed ID: 8678706 [TBL] [Abstract][Full Text] [Related]
16. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs. Uhl K; Kennedy DL; Kweder SL Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129 [TBL] [Abstract][Full Text] [Related]
17. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels. Ekstein D; Tirosh M; Eyal Y; Eyal S Epilepsy Behav; 2015 Mar; 44():218-24. PubMed ID: 25771206 [TBL] [Abstract][Full Text] [Related]
18. Worldwide analysis of factors associated with medicines compendia publishing. Arguello B; Fernandez-Llimos F Int J Clin Pharm; 2013 Jun; 35(3):386-92. PubMed ID: 23536106 [TBL] [Abstract][Full Text] [Related]
19. Drug formulary review process for sargramostim and filgrastim: focus on analysis of adverse drug reactions. Kellihan MJ Clin Ther; 1993; 15(5):927-37. PubMed ID: 7505717 [TBL] [Abstract][Full Text] [Related]
20. Overpromotion of drugs in international product package inserts. Osifo NG Trop Doct; 1983 Jan; 13(1):5-8. PubMed ID: 6836735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]